Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.
The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are application for Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy and others. The most of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is used for Moderately Emetogenic Chemotherapy, and the market share of that is about 52 % in 2017.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Eisai
Mylan
Mundipharma
Roche
Qilu Pharma
Novartis
Heron Therapeutics
Tesaro
Merck
Teva
By Type:
5-HT3 Inhibitors
NK1 Inhibitors
Other
By End-User:
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of 5-HT3 Inhibitors from 2016 to 2027
-
1.3.2 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of NK1 Inhibitors from 2016 to 2027
-
1.3.3 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Highly Emetogenic Chemotherapy from 2016 to 2027
-
1.4.2 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Moderately Emetogenic Chemotherapy from 2016 to 2027
-
1.4.3 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Low Emetogenic Chemotherapy from 2016 to 2027
-
1.4.4 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of 5-HT3 Inhibitors
-
3.4.2 Market Size and Growth Rate of NK1 Inhibitors
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in Highly Emetogenic Chemotherapy
-
4.4.2 Market Size and Growth Rate of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in Moderately Emetogenic Chemotherapy
-
4.4.3 Market Size and Growth Rate of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in Low Emetogenic Chemotherapy
-
4.4.4 Market Size and Growth Rate of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in Other
5 Market Analysis by Regions
-
5.1 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Analysis by Regions
-
5.2 USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis
-
6.1 West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types
-
6.2 West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users
7 South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis
-
7.1 South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types
-
7.2 South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users
8 Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis
-
8.1 Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users
9 Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis
-
9.1 Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Eisai
-
10.1.1 Eisai Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Mylan
-
10.2.1 Mylan Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Mundipharma
-
10.3.1 Mundipharma Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche
-
10.4.1 Roche Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Qilu Pharma
-
10.5.1 Qilu Pharma Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Novartis
-
10.6.1 Novartis Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Heron Therapeutics
-
10.7.1 Heron Therapeutics Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Tesaro
-
10.8.1 Tesaro Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Merck
-
10.9.1 Merck Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Teva
-
10.10.1 Teva Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of 5-HT3 Inhibitors from 2016 to 2027
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of NK1 Inhibitors from 2016 to 2027
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Highly Emetogenic Chemotherapy from 2016 to 2027
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Moderately Emetogenic Chemotherapy from 2016 to 2027
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Low Emetogenic Chemotherapy from 2016 to 2027
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 5-HT3 Inhibitors
-
Figure Market Size and Growth Rate of NK1 Inhibitors
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Highly Emetogenic Chemotherapy
-
Figure Market Size and Growth Rate of Moderately Emetogenic Chemotherapy
-
Figure Market Size and Growth Rate of Low Emetogenic Chemotherapy
-
Figure Market Size and Growth Rate of Other
-
Table USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production by Regions
-
Table USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions in 2016
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions in 2021
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Share by Regions in 2027
-
Table USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Regions
-
Table USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions in 2016
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions in 2021
-
Figure USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Regions in 2027
-
Table West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027
-
Table West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027
-
Table West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021
-
Figure West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027
-
Table South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027
-
Table South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027
-
Table South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021
-
Figure South USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027
-
Table Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by Types in 2027
-
Table Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Eisai
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
-
Figure Sales and Growth Rate Analysis of Eisai
-
Figure Revenue and Market Share Analysis of Eisai
-
Table Product and Service Introduction of Eisai
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Mundipharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma
-
Figure Sales and Growth Rate Analysis of Mundipharma
-
Figure Revenue and Market Share Analysis of Mundipharma
-
Table Product and Service Introduction of Mundipharma
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Qilu Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qilu Pharma
-
Figure Sales and Growth Rate Analysis of Qilu Pharma
-
Figure Revenue and Market Share Analysis of Qilu Pharma
-
Table Product and Service Introduction of Qilu Pharma
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Heron Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heron Therapeutics
-
Figure Sales and Growth Rate Analysis of Heron Therapeutics
-
Figure Revenue and Market Share Analysis of Heron Therapeutics
-
Table Product and Service Introduction of Heron Therapeutics
-
Table Company Profile and Development Status of Tesaro
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tesaro
-
Figure Sales and Growth Rate Analysis of Tesaro
-
Figure Revenue and Market Share Analysis of Tesaro
-
Table Product and Service Introduction of Tesaro
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
